FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,276 letters match. Newest first.

  1. Intas Pharmaceuticals Limited

    FDA cited Intas Pharmaceuticals for CGMP violations, including manipulated visual inspection records and inadequate sterile-drug controls.

    High risk
  2. AmLion Toothpaste Mfg. Sdn. Bhd.

    FDA cites AmLion Toothpaste in Malaysia for CGMP failures, including no testing of glycerin and sorbitol for DEG/EG; firm stays on import alert.

    High risk
  3. Cipla Limited

    FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.

    High risk
  4. Discover Health, LLC d/b/a Discover CBD and Strain Snobs

    FDA warns Discover Health over unapproved CBD, CBG, HHC, and Delta-8 THC drugs, unsafe CBD/Delta-8 foods, and unapproved animal drugs.

    High risk
  5. Cerci Kozmetik Ve Otel Ekipmanlari Pazarlama Ic Ve Dis Ticaret Limited Sirketi

    FDA: Turkish OTC drug maker Cerci shipped to the U.S. without finished-product identity and strength testing.

    High risk
  6. Xiamen Wally Bath Manufacture Co., Ltd.

    FDA warns Xiamen Wally Bath over current good manufacturing practice failures for over-the-counter hand sanitizer, including raw material and release testing gaps.

    High risk
  7. Melanie M. Hoppers, M.D./Physicians Quality Care

    FDA warns Dr. Melanie Hoppers over enrolling ineligible patients in a baloxavir marboxil influenza trial.

    High risk
  8. National Chemical Laboratories

    National Chemical Laboratories’ OTC topical drugs were adulterated after FDA found manufacturing quality violations, including untested BZK and weak quality oversight.

    High risk
  9. www.directpharmashop.net

    FDA warned DirectPharmaShop.net over selling unapproved, misbranded antipsychotics to U.S. consumers online.

    High risk
  10. Brenntag Great Lakes, LLC

    Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.

    High risk
  11. Elemental Herbs Inc. d/b/a ALL good

    Elemental Herbs (ALL good) cited for CGMP failures and unapproved, misbranded Goop Skin Recovery Balm.

    High risk
  12. Amazon.com, Inc.

    FDA warned Amazon for selling seven unapproved eye drug products on Amazon.com.

    High risk
  13. Saruhan Kimya Ve Temizlik Urunleri Sanayi Ticaret Anonim Sirketi Corlu Subesi

    FDA found manufacturing violations at Turkish OTC drug maker, including missing identity, release, and stability testing for hand sanitizers.

    High risk
  14. Global Pharma Healthcare Private Limited

    FDA warned Global Pharma Healthcare that non-sterile artificial tears and eye ointment from its India plant were tied to a Pseudomonas outbreak with four deaths.

    High risk
  15. Dexterity Health, LLC DBA Zazzee Naturals

    Zazzee Naturals sells Liquid MSM eye drops online as an unapproved new drug, FDA says in warning letter.

    High risk
  16. Samm Solutions, Inc., d.b.a. BTS Research

    Samm Solutions/BTS Research failed good laboratory practice (GLP) rules for nonclinical drug studies, FDA says.

    Medium
  17. Maria W. Greenwald, M.D.

    FDA warned Dr. Maria W. Greenwald over clinical trial violations involving investigational drugs, including ineligible subjects and inaccurate records.

    High risk
  18. ALI Pharmaceutical Manufacturing, LLC

    FDA says ALI Pharmaceutical Manufacturing failed to validate and control its porcine thyroid drug substance process, making the drug substance adulterated.

    High risk
  19. Handock Cosmetics Co., Ltd.

    FDA warns Handock Cosmetics over manufacturing quality failures and unapproved/mislabeled hand sanitizers from South Korea.

    High risk
  20. Hygienic Labs, LLC

    Hygienic Labs, an OTC drug manufacturer, failed to respond to FDA records requests.

    Medium
  21. Sun Pharmaceutical Industries Ltd.

    FDA warns Sun Pharmaceutical over CGMP violations in sterile injectable manufacturing at its Halol, India facility.

    High risk
  22. www.semaspace.com

    FDA warned semaspace.com for selling unapproved, misbranded injectable semaglutide drugs online without prescriptions.

    High risk
  23. www.gorillahealing.com

    FDA warned gorillahealing.com for selling unapproved, misbranded semaglutide and tirzepatide drugs to U.S. consumers online.

    High risk
  24. Seoul Cosmetics Co., Ltd.

    FDA warned Seoul Cosmetics, a South Korean drug maker, over poor manufacturing quality and unapproved OTC drugs.

    High risk
  25. www.alphamedstore.com

    FDA warned www.alphamedstore.com that it sells unapproved, illegally labeled opioid drugs, including Zomorph morphine capsules, to U.S. consumers.

    High risk
  26. Antonio E. Blanco, M.D./Vista Health Research, LLC

    FDA cited Dr. Antonio E. Blanco/Vista Health Research for enrolling ineligible trial subjects and missing required safety imaging.

    High risk
  27. Shot of Joy LLC

    FDA warned Shot of Joy LLC that its kratom and kava products are unapproved new drugs marketed for opioid addiction and other conditions.

    High risk
  28. Luis Javier Pena-Hernandez, M.D., FCCP

    FDA warns Dr. Pena-Hernandez over ineligible subject enrollment and lapsed IRB approval for investigational drugs.

    High risk
  29. Southern Tier Home Infusion, Inc. dba Pharmacy Innovations

    FDA warned compounding pharmacy Pharmacy Innovations that its sterile drugs were made under insanitary conditions and without valid patient prescriptions.

    High risk
  30. Zhao Qing Longda Biotechnology Co. Ltd.

    FDA says Zhao Qing Longda Biotechnology refused records access for OTC drugs, including children’s toothpaste, and placed its drugs on import alert.

    High risk
  31. Gulf States International, Inc.

    Gulf States International refused FDA requests for OTC drug manufacturing records, FDA says.

    Medium
  32. Maison Blanche LLC

    FDA warns Maison Blanche for refusing repeated requests for records on its OTC hand sanitizer.

    Medium
  33. Walgreen Company

    FDA warns Walgreen Company that its Walgreens Sensitive Extra Whitening drug listing is incomplete and inaccurate.

    Low
  34. Kor-Chem, Inc.

    Kor-Chem, Inc. made OTC hand sanitizer drugs with manufacturing violations, including shared equipment with industrial chemicals and missing identity and microbial testing.

    High risk
  35. PureChemPros LLC

    FDA warns PureChemPros over manufacturing quality failures and unapproved, misbranded hand sanitizer and hydrogen peroxide drugs.

    High risk
  36. Boiron, Inc.

    FDA warns Boiron that Optique 1 Eye Drops are an unapproved new drug sold with drug claims.

    High risk
  37. Natural Ophthalmics, Inc.

    FDA warned Natural Ophthalmics that six eye drop products are unapproved new drugs sold without FDA approval.

    High risk
  38. DR Vitamins, LLC dba DR Vitamin Solutions

    FDA warned DR Vitamin Solutions that its eye drops are unapproved new drugs and misbranded.

    High risk
  39. CVS Health

    FDA told CVS Health its unapproved Pink Eye Relief Drops are an illegal new drug made by a manufacturer with serious quality violations.

    High risk
  40. TRP Company, Inc

    FDA warns TRP Company that its homeopathic eye drops and ointments are unapproved new drugs and may be adulterated.

    High risk
  41. OcluMed LLC

    OcluMed sells unapproved eye drops with website claims to treat or prevent cataracts, FDA says.

    High risk
  42. Walgreens Boots Alliance, Inc.

    FDA warned Walgreens over three store-brand eye drops sold as unapproved new drugs and tied to contract manufacturer manufacturing violations.

    High risk
  43. Similasan AG

    Similasan AG's ophthalmic drugs are unapproved new drugs and violate CGMP (manufacturing quality rules), FDA says.

    High risk
  44. Safecor Health, LLC

    FDA warned drug repackager Safecor Health over CGMP failures that let tablets from other drugs contaminate packaging lines.

    High risk
  45. Green Pharmaceutical Co. Ltd.

    FDA warns South Korea's Green Pharmaceutical over OTC drug CGMP failures, including missing identity testing and weak quality unit.

    High risk
  46. Lex Inc.

    FDA warns Lex Inc. of Medley, Florida, that its over-the-counter drugs are adulterated because manufacturing rules were not met, including missing toxic-ingredient testing.

    High risk
  47. Gadal Laboratories Inc.

    FDA warned Gadal Laboratories of CGMP violations at its Miami drug plant, including unqualified suppliers and contamination risks in pediatric OTC drugs.

    High risk
  48. Cosmobeauti Laboratories & Manufacturing Inc.

    FDA warns Cosmobeauti Laboratories over manufacturing rule violations for OTC sunscreen drugs, including backdated batch records and missing microbial testing.

    High risk
  49. K.C. Pharmaceuticals Inc.

    FDA warned K.C. Pharmaceuticals after inspections found manufacturing rule violations in sterile ophthalmic drugs, including inadequate contamination controls and cleaning validation.

    High risk
  50. Molluscumaway LLC

    FDA warned Molluscumaway LLC that its molluscum patches, ointment, and body wash are unapproved new drugs.

    High risk